EKO International Corp. announced that its JV partnership NeuroVasc Clinical Inc. has entered into an agreement with the Meyer Institute in Hamilton Ontario to provide FREMS to its family of patients. The Meyer Institute is one of Canada's leaders in the treatment and management of diabetic wounds and limb care.

FREMS provide an FDA and Health Canada approved clinic based treatment that acts to increase vascularity and nerve function in diabetic patients who suffer from neuropathy. Dr. Paul Ziemer President of NeuroVasc Clinical has worked with the Meyer Institute in the past doing research into wound treatments. Neurovasc is in the process of completing the clinic installation which it anticipates will have 5 machines operating when fully completed with a capacity to treat 50 patients a day.